United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2018_register executive 2018-04-14 article Part II Rules and Regulations D09002ee1c7e8bc5e D09002ee1c7e8bfd4 United States Department of Health and Human Services originator org United States Government Agency or Subagency United States Centers for Medicare & Medicaid Services originator org United States Government Agency or Subagency This final rule will revise the Medicare Advantage (MA) program (Part C) regulations and Prescription Drug Benefit program (Part D) regulations to implement certain provisions of the Comprehensive Addiction and Recovery Act (CARA) to further reduce the number of beneficiaries who may potentially misuse or overdose on opioids while still having access to important treatment options; implement certain provisions of the 21st Century Cures Act; support innovative approaches to improve program quality, accessibility, and affordability; offer beneficiaries more choices and better care; improve the CMS customer experience and maintain high beneficiary satisfaction; address program integrity policies related to payments based on prescriber, provider and supplier status in MA, Medicare cost plan, Medicare Part D and the PACE programs; provide an update to the official Medicare Part D electronic prescribing standards; and clarify program requirements and certain technical changes regarding treatment of Medicare Part A and Part B appeal rights related to premiums adjustments. 83 FR 16440 https://www.govinfo.gov/app/details/FR-2018-04-16/2018-07179 2018-07179 fr16ap18-12 RIN 0938-AT08 4120-01-P CMS-4182-F https://www.govinfo.gov/app/details/FR-2018-04-16/2018-07179 https://www.govinfo.gov/content/pkg/FR-2018-04-16/html/2018-07179.htm https://www.govinfo.gov/content/pkg/FR-2018-04-16/pdf/2018-07179.pdf Administrative Practice and Procedure Health Facilities Health Professions Kidney Diseases Medical Devices Medicare Reporting and Recordkeeping Requirements Rural Areas X-Rays Grant Programs-Health Health Care Health Insurance Health Maintenance Organizations (Hmo) Loan Programs-Health Penalties Privacy Emergency Medical Services Health Professionals Incorporation by Reference Aged Health Records Medicaid 318 p. 16440 16757 83 FR 16440 Title 42 Part 405 42 CFR Part 405 Title 42 Part 417 42 CFR Part 417 Title 42 Part 422 42 CFR Part 422 Title 42 Part 423 42 CFR Part 423 Title 42 Part 460 42 CFR Part 460 Title 42 Part 498 42 CFR Part 498 RIN 0938-AT08 Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program; Federal Register Vol. 83, Issue RULE 2018-07179 II DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services 2018-06-15 CMS-4182-F 4120-01-P 2018-07179 Final rule.

This final rule will revise the Medicare Advantage (MA) program (Part C) regulations and Prescription Drug Benefit program (Part D) regulations to implement certain provisions of the Comprehensive Addiction and Recovery Act (CARA) to further reduce the number of beneficiaries who may potentially misuse or overdose on opioids while still having access to important treatment options; implement certain provisions of the 21st Century Cures Act; support innovative approaches to improve program quality, accessibility, and affordability; offer beneficiaries more choices and better care; improve the CMS customer experience and maintain high beneficiary satisfaction; address program integrity policies related to payments based on prescriber, provider and supplier status in MA, Medicare cost plan, Medicare Part D and the PACE programs; provide an update to the official Medicare Part D electronic prescribing standards; and clarify program requirements and certain technical changes regarding treatment of Medicare Part A and Part B appeal rights related to premiums adjustments.

Effective Date: This rule is effective June 15, 2018. Theresa Wachter, (410) 786-1157, Part C Issues. Administrative Practice and Procedure Health Facilities Health Professions Kidney Diseases Medical Devices Medicare Reporting and Recordkeeping Requirements Rural Areas X-Rays Grant Programs-Health Health Care Health Insurance Health Maintenance Organizations (Hmo) Loan Programs-Health Penalties Privacy Emergency Medical Services Health Professionals Incorporation by Reference Aged Health Records Medicaid Medicare Program: Contract Year 2019 Policy and Technical Changes to Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, Medicare Prescription Drug Benefit Programs, and PACE Program , MP-CAHPS@cms.hhs.gov PartCandDStarRatings@cms.hhs.gov PARTCDQA@cms.hhs.gov CMS.gov http://consumersunion.org/pdf/Too_Much_Choice_Nov_2012.pdf http://go.cms.gov/partcanddstarratings http://hosonline.org/globalassets/hos-online/survey-results/hos_casemix_coefficient_tables_c17.pdf http://info.urac.org/specialtypharmacyreport http://journals.sagepub.com/doi/pdf/10.1177/1077558706293636 http://stats.oecd.org/index.aspx?DataSetCode=HEALTH_STAT http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Reports.ReportsMenu http://www.ahrq.gov/cahps/about-cahps/patient-experience/index.html http://www.bls.gov/oes/current/oes_nat.htm http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/Biosimilars/ http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/Biosimilars/ucm411418.htm http://www.internetsociety.org/globalinternetreport/2016/?gclid=EAIaIQobChMI-tz1nN_W1QIVgoKzCh1EVggBEAAYASAAEgLpj_D_BwE http://www.mahp.com/unify-files/HMAFinalSCOWhitePaper_2015_07_21.pdf http://www.medpac.gov/docs/default-source/reports/chapter-3-appendixes-care-coordination-programs-for-dual-eligible-beneficiaries-june-2012-report-.pdf?sfvrsn=0 http://www.medpac.gov/docs/default-source/reports/march-2016-report-to-the-congress-medicare-payment-policy.pdf http://www.medpac.gov/docs/default-source/reports/march-2016-report-to-the-congress-medicare-payment-policy.pdf?sfvrsn=0 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513347/ http://www.ncpa.co/pdf/NCPA-Comments-to-CMS-Proposed-Rule-2015FINAL-3.7.14.pdf http://www.ncpa.co/pdf/ncpa-medicaid-recommend-cms-june-2017.pdf http://www.ncqa.org/hedis-quality-measurement/research/hedis-and-the-impact-act http://www.ncqa.org/HEDISQualityMeasurement/HEDISMeasures.aspx http://www.pewinternet.org/2017/05/17/tech-adoption-climbs-among-older-adults/ http://www.sba.gov/content/small-business-size-standards https://aspe.hhs.gov/pdf-report/report-congress-social-risk-factors-and-performance-under-medicares-value-based-purchasing-programs https://aspe.hhs.gov/report/minnesota-managed-care-longitudinal-data-analysis https://innovation.cms.gov/Files/x/mtm-announcement.pdf https://innovation.cms.gov/initiatives/vbid/ https://obamawhitehouse.archives.gov/omb/circulars_a004_a-4/ https://onlinelibrary.wiley.com/doi/full/10.1111/j.1475-6773.2004.00261.x https://www.bls.gov/oes/2016/may/naics4_621100.htm https://www.bls.gov/oes/current/oes152011.htm https://www.brookings.edu/wp-content/uploads/2017/11/ma-consumer-reforms.pdf https://www.cdc.gov/drugoverdose/data-files/CDC_Oral_Morphine_Milligram_Equivalents_Sept_2017.xlsx https://www.cms.gov/ https://www.cms.gov/About-CMS/Agency-Information/OMH/research-and-data/statistics-and-data/stratified-reporting.html https://www.cms.gov/Medicare/Compliance-and-Audits/Part-C-and-Part-D-Compliance-and-Audits/Downloads/Final_2018_Application_Cycle_Past_Performance_Methodology.pdf https://www.cms.gov/Medicare/Eligibility-and-Enrollment/MedicareMangCareEligEnrol/Downloads/CY_2018_MA_Enrollment_and_Disenrollment_Guidance_6-15-17.pdf https://www.cms.gov/Medicare/Eligibility-and-Enrollment/MedicareMangCareEligEnrol/Downloads/HPMS_Memo_Seamless_Moratorium.pdf https://www.cms.gov/Medicare/Eligibility-and-Enrollment/MedicareMangCareEligEnrol/index.html?redirect=/MedicareMangCareEligEnrol/ https://www.cms.gov/Medicare/Health-Plans/ManagedCareMarketing/Downloads/CY-2018-Medicare-Marketing-Guidelines_Final072017.pdf https://www.cms.gov/Medicare/Health-Plans/MedicareAdvtgSpecRateStats/Announcements-and-Documents.html https://www.cms.gov/Medicare/Health-Plans/MedicareAdvtgSpecRateStats/Downloads/Announcement2013.pdf https://www.cms.gov/Medicare/Health-Plans/MedicareAdvtgSpecRateStats/downloads/Announcement2014.pdf https://www.cms.gov/Medicare/Medicare-dvantage/MedicareAdvantageApps/index.html https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/Concurrent-Use-of-Opioids-and-Benzodiazepines-in-a-Medicare-Part-D-Population-CY-2015.pdf https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/downloads/LTCGuidance.pdf https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/MemoPDBManualChapter5_093011.pdf https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/Revised-OMS-Criteria-Modification-Analysis.pdf https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/PartCDDataValidation.html https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/RxContracting_FormularyGuidance.html https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/RxContracting_ReportingOversight.html https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/RxUtilization.html https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovGenIn/Downloads/HPMS-Memo-Prescriber-Enrollment-Enforcement-v06012015.pdf https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovGenIn/Downloads/Industry-wide-Appeals-Timeliness-Monitoring-Memo-November-28-2016.pdf https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovGenIn/Downloads/Industry-wide-Timeliness-Monitoring.pdf https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovGenIn/Downloads/Research-on-the-Impact-of-Socioeconomic-Status-on-Star-Ratingsv1-09082015.pdf https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovGenIn/OOPCResources.html https://www.cms.gov/medicare/prescription-drug-coverage/prescriptiondrugcovgenin/performancedata.html https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/MMS/Downloads/Access-Measures.pdf https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/mc86c04.pdf https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/internet-Only-Manuals-IOMs-Items/CMS019326.html https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing-Items/CMS-10476.html https://www.cms.gov/reportstrustfunds https://www.cms.gov/reportstrustfunds/ https://www.cms.gov/Research-Statistics-Data-and-Systems/Computer-Data-and-Systems/HPMS/HPMS-Memos-Archive-Annual-Items/SysHPMS-Memo-Archive-%E2%80%93-2015-Qtr1.html https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/ReportsTrustFunds/ https://www.drugabuse.gov/drugs-abuse/opioids/benzodiazepines-opioids https://www.fda.gov/Drugs/DrugSafety/ucm518473.htm https://www.fda.gov/drugs/resourcesforyou/consumers/questionsanswers/ucm100100.htm https://www.ma-pdpcahps.org https://www.nap.edu/catalog/21858/accounting-for-social-risk-factors-in-medicare-payment-identifying-social https://www.opm.gov/policy-data-oversight/pay-leave/salaries-wages/2017/general-schedule/ internetSociety.org ma-pdpcahps.org Medicare.gov www.cms.gov www.medicare.gov www.ncpdp.org www.qualityforum.org/risk_adjustment_ses.aspx Vol. 83, no. 73 Office of the Federal Register, National Archives and Records Administration 2018-04-16 continuing daily deposited born digital 592 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2018-04-16 P0b002ee19a0ce24a 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr16ap18 https://www.govinfo.gov/app/details/FR-2018-04-16 https://www.govinfo.gov/content/pkg/FR-2018-04-16/pdf/FR-2018-04-16.pdf https://www.govinfo.gov/content/pkg/FR-2018-04-16/xml/FR-2018-04-16.xml fdlp 16183 16765 DGPO 2018-04-14 2024-06-01 FR-2018-04-16 machine generated eng FR FR-2018-04-16 83 73